首页> Psychopharmacology> Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review.

Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review.

导出原文传递

翻译打印收藏纠错

第一作者： Halford,Warlick Iv

第一单位： Dr. Kiran C. Patel College of Osteopathic Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, Fort Lauderdale, Florida, USA. halfordwarlick@yahoo.com.

作者： Halford,Warlick Iv ^[1] ; Darcy,Tocci ^[2] ; Sukriti,Prashar ^[3] ; Erick,Boldt ^[3] ; Alena,Khalil ^[3] ; Simran,Arora ^[3] ; Thomas,Matthews ^[3] ; Talha,Wahid ^[3] ; Richard,Fernandez ^[3] ; Dhiya,Ram ^[3] ; Lexie,Leon ^[3] ; Arisha,Arain ^[4] ; Jose,Rey ^[5] ; Kelley,Davis ^[2]

作者单位： Dr. Kiran C. Patel College of Osteopathic Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, Fort Lauderdale, Florida, USA. halfordwarlick@yahoo.com. ^[1] Dr. Kiran C. Patel College of Allopathic Medicine, Health Profession Division, Nova Southeastern University, Fort Lauderdale, Florida, USA. ^[2] Dr. Kiran C. Patel College of Osteopathic Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, Fort Lauderdale, Florida, USA. ^[3] Halmos College of Arts and Sciences, Nova Southeastern University, Fort Lauderdale, Florida, USA. ^[4] College of Pharmacy, Health Profession Division, Nova Southeastern University, Fort Lauderdale, Florida, USA. ^[5]

关键词 Amphetamines Attention deficit hyperactivity disorder Bupropion Dopamine Methylphenidate Neurodevelopmental disorder Norepinephrine Omega-3 fatty acids Vesicular monoamine transporter pH gradient model